US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Krystal Biotech Inc.

147.49

-2.6600-1.77%

Post-market: 147.490.00000.00%19:50 EDT

Volume:304.07K

Turnover:44.93M

Market Cap:4.26B

PE:35.49

High:152.25

Open:151.33

Low:146.35

Close:150.15

Loading ...

Overview Company News Filings

Sanofi & Regeneron's Dupixent Receives FDA Nod for Urticaria

Krystal Biotech to Report First Quarter 2025 Financial Results on May 6, 2025

Bank of America Securities Sticks to Their Buy Rating for Krystal Biotech (KRYS)

Fate Therapeutics' Lupus Candidate FT819 Gets FDA RMAT Tag

Ironwood Shares Tank on Regulatory Update for Apraglutide

Arcturus Gets FDA's Fast Track Tag for Influenza Vaccine Candidate

TG Therapeutics Shares Rise Almost 30% in 3 Months: Here's Why

Is Kiniksa Pharmaceuticals (KNSA) Outperforming Other Medical Stocks This Year?

Jeune Aesthetics Appoints Marc Forth As Chief Executive Officer

Krystal Biotech’s Jeune Aesthetics names Marc Forth as CEO

Jeune Aesthetics Appoints Marc Forth as Chief Executive Officer

THOMSON REUTERS

Press Release: Jeune Aesthetics Appoints Marc Forth as Chief Executive Officer

5 Biotech Stocks Worth Adding Amid Global Uncertainty in 2025

AZN Gets EU Nod for Expanded Use of Two Separate Cancer Drugs

AMGN's Uplizna Gets FDA Nod for 2nd Rare Autoimmune Disease Indication

SNY's Rilzabrutinib Gets FDA's Orphan Drug Tag for Two Rare Diseases

William Blair Keeps Their Buy Rating on Krystal Biotech (KRYS)

Alkermes Begins Idiopathic Hypersomnia Study on ALKS 2680

VRTX Provides Mixed Updates for Type 1 Diabetes Pipeline Candidates

Mirum Pharmaceuticals (MIRM) Down 1.9% Since Last Earnings Report: Can It Rebound?

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/KRYS/news?page=3"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"KRYS","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"KRYS\",,,,,undefined,":{"symbol":"KRYS","market":"US","secType":"STK","nameCN":"Krystal Biotech Inc.","latestPrice":147.49,"timestamp":1752868800000,"preClose":150.15,"halted":0,"volume":304071,"hourTrading":{"tag":"盘后","latestPrice":147.49,"preClose":147.49,"latestTime":"19:50 EDT","volume":19043,"amount":2808343.81,"timestamp":1752882618343},"delay":0,"floatShares":22828506,"shares":28898680,"eps":4.155478,"marketStatus":"Market Closed","change":-2.66,"latestTime":"07-18 16:00:00 EDT","open":151.33,"high":152.2475,"low":146.35,"amount":44932842.29319,"amplitude":0.039277,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":4.155478,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1753084800000},"marketStatusCode":7,"adr":0,"adrRate":0,"listingDate":1505880000000,"exchange":"NASDAQ","adjPreClose":150.15,"preHourTrading":{"tag":"盘前","latestPrice":154.22,"preClose":150.15,"latestTime":"09:27 EDT","volume":101,"amount":15233.89969,"timestamp":1752845220653},"postHourTrading":{"tag":"盘后","latestPrice":147.49,"preClose":147.49,"latestTime":"19:50 EDT","volume":19043,"amount":2808343.81,"timestamp":1752882618343},"volumeRatio":1.079821,"impliedVol":0.6353,"impliedVolPercentile":0.812},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"KRYS\",,,,,undefined,":{"symbol":"KRYS","floatShares":22828506,"roa":"8.66%","roe":"13.90%","lyrEps":3.118319,"volumeRatio":1.079821,"shares":28898680,"dividePrice":0,"high":152.2475,"amplitude":0.039277,"preClose":150.15,"low":146.35,"week52Low":122.8,"pbRate":"4.33","psRate":"12.78","week52High":219.34,"institutionHeld":0,"latestPrice":147.49,"eps":4.155478,"divideRate":0,"volume":304071,"delay":0,"ttmEps":4.155478,"open":151.33,"prevYearClose":156.66,"prevWeekClose":148.17,"prevMonthClose":137.46,"prevQuarterClose":137.46,"fiveDayClose":148.17,"twentyDayClose":132.09,"sixtyDayClose":168.8},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"KRYS\",pageSize:20,pageCount:3,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2529389778","title":"Sanofi & Regeneron's Dupixent Receives FDA Nod for Urticaria","url":"https://stock-news.laohu8.com/highlight/detail?id=2529389778","media":"Zacks","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529389778?lang=en_us&edition=fundamental","pubTime":"2025-04-21 21:22","pubTimestamp":1745241720,"startTime":"0","endTime":"0","summary":"Sanofi SNY and partner Regeneron REGN announced that the FDA approved Dupixent  for the treatment of chronic spontaneous urticaria  in adults and adolescents aged 12 years and above, who remain symptomatic despite histamine-1  antihistamine treatment.Following the latest FDA nod, Dupixent became the first new targeted therapy to be approved for CSU in more than a decade. The drug is now approved for seven type II inflammatory diseases in the United States.Dupixent is already approved in several countries, including the United States and the European Union, for treating severe chronic rhinosinusitis with nasal polyposis, severe asthma, moderate-to-severe atopic dermatitis, eosinophilic esophagitis, prurigo nodularis and chronic obstructive pulmonary disease.CSU is an inflammatory skin condition, primarily occurring due to type 2 inflammation. This causes sudden and debilitating hives and swelling on the skin, which is mostly inadequately controlled by antihistamine treatment.Year to dat","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/sanofi-regenerons-dupixent-receives-fda-132200561.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU0109394709.USD","LU2362540622.SGD","REGN","LU1974910355.USD","LU0289739699.SGD","BK4532","LU0114720955.EUR","BK4588","IE00BFXG1179.USD","LU0058720904.USD","BK4585","BK4139","LU2237438978.USD","SNYNF","LU2468319806.SGD","LU0823416689.USD","LU0320765992.SGD","LU2362541273.HKD","LU0882574055.USD","LU0889565916.HKD","LU2023250504.SGD","LU2362541513.USD","LU0053666078.USD","LU2106854487.HKD","BK4533","IE00BN0W2W23.USD","LU1917777945.USD","IE00BN0W2T93.GBP","JAZZ","LU2089984988.USD","IE00BN0W2V16.EUR","SNY","KRYS","BK4007"],"gpt_icon":0},{"id":"2528638717","title":"Krystal Biotech to Report First Quarter 2025 Financial Results on May 6, 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2528638717","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2528638717?lang=en_us&edition=fundamental","pubTime":"2025-04-17 20:00","pubTimestamp":1744891200,"startTime":"0","endTime":"0","summary":"PITTSBURGH, April 17, 2025  -- Krystal Biotech, Inc.  , a commercial-stage biotechnology company, today announced that it will report its first quarter 2025 financial results onTuesday, May 6, 2025, prior to the open of U.S. markets.The Company’s management will also host a conference call and webcast at8:30 am ET onTuesday, May 6, 2025, to discuss the financial results and provide a business update.CONTACTInvestors and Media:Stéphane Paquette, PhDKrystal Biotechspaquette@krystalbio.com","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/krystal-biotech-report-first-quarter-120000088.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4139","KRYS"],"gpt_icon":0},{"id":"2528797075","title":"Bank of America Securities Sticks to Their Buy Rating for Krystal Biotech (KRYS)","url":"https://stock-news.laohu8.com/highlight/detail?id=2528797075","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2528797075?lang=en_us&edition=fundamental","pubTime":"2025-04-17 18:58","pubTimestamp":1744887487,"startTime":"0","endTime":"0","summary":"Bank of America Securities analyst Alec Stranahan maintained a Buy rating on Krystal Biotech (KRYS – Research Report) today and set a price target ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/bank-of-america-securities-sticks-to-their-buy-rating-for-krystal-biotech-krys?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/bank-of-america-securities-sticks-to-their-buy-rating-for-krystal-biotech-krys?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["KRYS"],"gpt_icon":0},{"id":"2527015440","title":"Fate Therapeutics' Lupus Candidate FT819 Gets FDA RMAT Tag","url":"https://stock-news.laohu8.com/highlight/detail?id=2527015440","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527015440?lang=en_us&edition=fundamental","pubTime":"2025-04-15 22:42","pubTimestamp":1744728120,"startTime":"0","endTime":"0","summary":"Fate Therapeutics FATE recently announced that the FDA has granted the Regenerative Medicine Advanced Therapy  designation to its investigational pipeline candidate FT819 for the treatment of active moderate to severe systemic lupus erythematosus , including lupus nephritis.The RMAT designation provides the candidate with increased opportunities to meet FDA officials, as well as arrange early meetings to discuss potential surrogate or intermediate endpoints. It opens up early interactions between the FDA and sponsors to facilitate accelerated approval and potential priority review of a product’s biologics license application.FT819 is an off-the-shelf, iPSC-derived CAR T-cell product candidate comprised of CD8αβ+ T cells with a memory phenotype and high CXCR4 expression to promote tissue trafficking.The latest RMAT designation by the FDA underlines the potential of FT819 to address an area of significant unmet medical needs.Year to date, shares of Fate Therapeutics have plunged 44% comp","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/fate-therapeutics-lupus-candidate-ft819-144200510.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4139","FATE","IE00BN0W2V16.EUR","BK4532","BK4533","IE00BN0W2T93.GBP","SLE","LU0320765992.SGD","KRYS","LU0109394709.USD","ADMA","BK4077","BK4007","IE00BN0W2W23.USD","JAZZ","LU0823416689.USD","LU0889565916.HKD"],"gpt_icon":0},{"id":"2527449519","title":"Ironwood Shares Tank on Regulatory Update for Apraglutide","url":"https://stock-news.laohu8.com/highlight/detail?id=2527449519","media":"Zacks","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527449519?lang=en_us&edition=fundamental","pubTime":"2025-04-15 21:18","pubTimestamp":1744723080,"startTime":"0","endTime":"0","summary":"Shares of Ironwood Pharmaceuticals IRWD plunged 31.5% yesterday after it announced regulatory updates on the next-generation GLP-2 analog, apraglutide, which is being developed for treating short bowel syndrome  with intestinal failure .Following the recent discussion with the FDA, management noted that a confirmatory phase III study will be required to seek approval of apraglutide for patients with SBS-IF and dependent on parenteral support.Simultaneously, IRWD is looking to explore alternatives aimed at maximizing shareholder value.Ironwoodinitiated the rolling new drug application submission to the FDA for apraglutide to treat SBS patients who are dependent on parenteral support in January 2025.However, following the latest discussion with the FDA, a confirmatory phase III study will now be required for apraglutide approval. This, in turn, is likely to extend the timeline for the NDA filing completion and also potentially delay the approval for apraglutide.In the past 60 days, estim","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/ironwood-shares-tank-regulatory-apraglutide-131800007.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["IE00BN0W2T93.GBP","LU0320765992.SGD","KRYS","LU0109394709.USD","LU0889565916.HKD","BK4139","JAZZ","BK4532","BK4007","BK4533","IE00BN0W2W23.USD","IRWD","LU0823416689.USD","ADMA","IE00BN0W2V16.EUR"],"gpt_icon":0},{"id":"2526233615","title":"Arcturus Gets FDA's Fast Track Tag for Influenza Vaccine Candidate","url":"https://stock-news.laohu8.com/highlight/detail?id=2526233615","media":"Zacks","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526233615?lang=en_us&edition=fundamental","pubTime":"2025-04-11 23:49","pubTimestamp":1744386540,"startTime":"0","endTime":"0","summary":"Arcturus Therapeutics Holdings Inc. ARCT announced that the FDA has granted a Fast Track designation to its self-amplifying mRNA  vaccine candidate, ARCT-2304, for active immunization to protect against the influenza A H5N1 virus.The Fast Track designation from the FDA facilitates rapid development and expedites the review of vaccines that are being developed to treat serious conditions and have the potential to address unmet medical needs.The Fast Track tag is likely to expedite the development path for ARCT-2304 and help in faster regulatory filing for the vaccine in the United States.In November 2024, the FDA cleared the investigational new drug  application to begin clinical studies on the sa-mRNA vaccine candidate, ARCT-2304, for active immunization to prevent pandemic influenza disease caused by the H5N1 virus.Arcturus developed the first sa-mRNA COVID-19 vaccine, Kostaive. The company has a collaboration agreement with renowned vaccine company CSL Seqirus for making innovative m","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/arcturus-gets-fdas-fast-track-154900033.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4533","BK4588","CF","BK4007","BK4093","ADMA","BK4551","BK4532","IE00BN0W2V16.EUR","BK4535","BK4548","JAZZ","LU0823416689.USD","BK4568","IE00BN0W2T93.GBP","LU0109394709.USD","BK4585","BK4139","FAST","KRYS","LU0889565916.HKD","LU0320765992.SGD","ARCT","BNTX","IE00BN0W2W23.USD"],"gpt_icon":0},{"id":"2526517347","title":"TG Therapeutics Shares Rise Almost 30% in 3 Months: Here's Why","url":"https://stock-news.laohu8.com/highlight/detail?id=2526517347","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526517347?lang=en_us&edition=fundamental","pubTime":"2025-04-10 23:50","pubTimestamp":1744300200,"startTime":"0","endTime":"0","summary":"Shares of TG Therapeutics, Inc. TGTX have rallied 29.5% in the past three months against the industry’s decline of 11.2%.The company’s sole marketed drug Briumvi  was approved by the FDA for the treatment of adult patients with relapsing forms of multiple sclerosis  in December 2022. Sales of the drug exceeded management’s expectations in 2024.The company’s top line primarily comprises product sales from Briumvi and royalty and other revenues.Briumvi has been witnessing strong adoption from patients in recent quarters and the trend is likely to continue in 2025. Net product sales of Briumvi were $313.7 million in 2024 compared with $92 million recorded in 2023.The better-than-expected sales performance of Briumvi can be attributed as the reason for the stock’s increase during the said time.In the past 60 days, estimates for Jazz Pharmaceuticals’ earnings per share have increased from $22.11 to $23.33 for 2025. During the same time, earnings per share estimates for 2026 increased from $","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/tg-therapeutics-shares-rise-almost-155000776.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["IE00BN0W2T93.GBP","IE00BKVL7J92.USD","IE00BZ1G4Q59.USD","LU0106831901.USD","BK4516","BK4504","JAZZ","LU1548497426.USD","BK4139","BK4533","LU0106261372.USD","LU1162221912.USD","LU2347655156.SGD","TGTX","LU1363072403.SGD","TG","LU2133065610.SGD","IE00BN0W2V16.EUR","LU0225283273.USD","LU2089284900.SGD","BK4007","BK4153","LU1720051017.SGD","LU2028103732.USD","LU1732799900.SGD","LU2111349929.HKD","LU0889565916.HKD","BK4581","LU0006306889.USD","LU0795875169.SGD","DTIL","LU2089283258.USD","KRYS","IE00BN0W2W23.USD","LU0971096721.USD","LU0320765646.SGD","BK4090","BK4534","BK4127","LU0795875086.SGD","LU0267386448.USD","BK4585","LU0158827781.USD","LU0158827948.USD","LU1668664300.SGD","BK4532","LU0320765992.SGD","LU0109394709.USD","LU1074936037.SGD","LU0314104364.USD"],"gpt_icon":0},{"id":"2526202810","title":"Is Kiniksa Pharmaceuticals (KNSA) Outperforming Other Medical Stocks This Year?","url":"https://stock-news.laohu8.com/highlight/detail?id=2526202810","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526202810?lang=en_us&edition=fundamental","pubTime":"2025-04-08 21:40","pubTimestamp":1744119605,"startTime":"0","endTime":"0","summary":"The Medical group has plenty of great stocks, but investors should always be looking for companies that are outperforming their peers. Has Kiniksa Pharmaceuticals, Ltd.  been one of those stocks this year?Let's take a closer look at the stock's year-to-date performance to find out.Kiniksa Pharmaceuticals, Ltd. is one of 1003 individual stocks in the Medical sector. Collectively, these companies sit at #5 in the Zacks Sector Rank. The Zacks Sector Rank includes 16 different groups and is listed in order from best to worst in terms of the average Zacks Rank of the individual companies within each of these sectors.The Zacks Rank is a successful stock-picking model that emphasizes earnings estimates and estimate revisions. The system highlights a number of different stocks that could be poised to outperform the broader market over the next one to three months. Kiniksa Pharmaceuticals, Ltd. is currently sporting a Zacks Rank of #2 .Our latest available data shows that KNSA has returned abou","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/kiniksa-pharmaceuticals-knsa-outperforming-other-134005274.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["KRYS","KNSA"],"gpt_icon":0},{"id":"2525071238","title":"Jeune Aesthetics Appoints Marc Forth As Chief Executive Officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2525071238","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2525071238?lang=en_us&edition=fundamental","pubTime":"2025-04-08 04:56","pubTimestamp":1744059416,"startTime":"0","endTime":"0","summary":"April 7 (Reuters) - Krystal Biotech Inc ::*JEUNE AESTHETICS APPOINTS MARC FORTH AS CHIEF EXECUTIVE OFFICER  ((Reuters Investor Briefs; email: reutersinvestor.briefs@thomsonreuters.com))  Source Date/Time = 07-APR-202520:30:00.057 GMT","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250407:nRSD1fVlTG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KRYS","BK4139"],"gpt_icon":0},{"id":"2525717560","title":"Krystal Biotech’s Jeune Aesthetics names Marc Forth as CEO","url":"https://stock-news.laohu8.com/highlight/detail?id=2525717560","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2525717560?lang=en_us&edition=fundamental","pubTime":"2025-04-08 04:40","pubTimestamp":1744058429,"startTime":"0","endTime":"0","summary":"Jeune Aesthetics, a wholly owned subsidiary of Krystal Biotech (KRYS), announced the appointment of Marc Forth as Chief Executive Officer effective...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/krystal-biotechs-jeune-aesthetics-names-marc-forth-as-ceo?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/krystal-biotechs-jeune-aesthetics-names-marc-forth-as-ceo?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["KRYS","BK4139"],"gpt_icon":0},{"id":"2525079526","title":"Jeune Aesthetics Appoints Marc Forth as Chief Executive Officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2525079526","media":"THOMSON REUTERS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2525079526?lang=en_us&edition=fundamental","pubTime":"2025-04-08 04:30","pubTimestamp":1744057800,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250407:nTUA3YLQP1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["KRYS","BK4139"],"gpt_icon":0},{"id":"2525796810","title":"Press Release: Jeune Aesthetics Appoints Marc Forth as Chief Executive Officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2525796810","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2525796810?lang=en_us&edition=fundamental","pubTime":"2025-04-08 04:30","pubTimestamp":1744057800,"startTime":"0","endTime":"0","summary":"PITTSBURGH, April 07, 2025  -- Jeune Aesthetics, Inc. , a wholly owned subsidiary of Krystal Biotech, Inc.   leveraging Krystal's clinically validated gene-delivery platform to fundamentally address and reverse the biology of aging skin, announced today the appointment of Marc Forth as Chief Executive Officer , effective today. A veteran of the healthcare industry, Mr. Forth has over 30 years of commercial and executive leadership experience, with an extensive track record of building innovative companies as well as launching and commercializing leading brands, including BOTOX , one of the most widely recognized global brands. Mr. Forth has also served as a valuable contributor on Jeune's board of directors since February 2021.\"I am thrilled to be joining Jeune as CEO as it takes the next step forward in its growth journey,\" said Mr. Forth. \"With Krystal's FDA-validated gene delivery platform at its core, Jeune is uniquely positioned to meet the growing demand for fundamentally rejuven","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4022","BK4232","BK4139","CEO","KRYS","R"],"gpt_icon":0},{"id":"2525207390","title":"5 Biotech Stocks Worth Adding Amid Global Uncertainty in 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2525207390","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2525207390?lang=en_us&edition=fundamental","pubTime":"2025-04-08 01:22","pubTimestamp":1744046520,"startTime":"0","endTime":"0","summary":"The current macro environment appears grim, given the uncertainty around the global trade war, along with ongoing geopolitical tension. While 2025 started on an encouraging note and strong quarterly results buoyed investor optimism, a likely overall slowdown does not bode well. Nonetheless, given the continuous need for innovative medical treatments, irrespective of the state of the economy, the dynamic biotech industry will continue to grab investors’ interest despite the inherent volatility and uncertain macroeconomic environment.M&A activity is likely to accelerate in 2025 under the Trump administration and expected deregulation. Pharma and biotech industry leaders consistently seek to expand their product portfolios and pipelines through strategic collaborations and acquisitions. While oncology and immuno-oncology companies have always been at the top of acquisition targets, the lucrative obesity sector and gene-editing space are in spotlight as of now.Biotech companies like Gilead","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/5-biotech-stocks-worth-adding-172200110.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU0289739699.SGD","SDS","BK4588","IE00BZ1G4Q59.USD","LU2065171402.SGD","ADMA","BK4504","FOLD","LU1066051498.USD","LU1571399168.USD","LU2468319806.SGD","BK4532","GILD","IE00B19Z3B42.SGD","BK4550","IE00BKVL7J92.USD","BK4559","OEX","SH","SSO","BK4581","OEF","BMRN","BK4534","LU0234570918.USD","LU1839511570.USD","LU1066053197.SGD","VOO","LU0058720904.USD","LU1585245621.USD","LU2065170008.USD","LU2089984988.USD",".SPX","LU2065171311.SGD","BK4583","IE00B3T34201.USD","BK4585","BK4139","KRYS","LU0889565916.HKD","SPY","LU0320765992.SGD","IVV","BK4578","LU2065169927.USD","IE0002270589.USD","ESmain"],"gpt_icon":1},{"id":"2525602133","title":"AZN Gets EU Nod for Expanded Use of Two Separate Cancer Drugs","url":"https://stock-news.laohu8.com/highlight/detail?id=2525602133","media":"Zacks","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2525602133?lang=en_us&edition=fundamental","pubTime":"2025-04-07 22:53","pubTimestamp":1744037580,"startTime":"0","endTime":"0","summary":"AstraZeneca AZN and partner Daiichi Sankyo announced that the European Commission has approved the expanded use of Enhertu  in breast cancer.The regulatory body has now approved Enhertu as a monotherapy for treating metastatic HR-positive, HER2-low or HER2-ultralow breast cancer in adult patients who have received at least one endocrine therapy in the metastatic setting and are not considered suitable for the therapy as the next line of treatment in the European Union .The latest nod in the EU expands the approved indication of Enhertu in HER2-low metastatic breast cancer to include use in an earlier disease setting as well as in a broader patient population that includes HER2-ultralow.Year to date, shares of AstraZeneca have risen 4.5% against the industry’s decrease of 5.8%.EU Nod for Enhertu Based on AZN's DESTINY-Breast06 Study Data. The approval in the EU was expected as the Committee for Medicinal Products for Human Use recommended approval of Enhertu for the given indication in ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/azn-gets-eu-nod-expanded-145300661.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["AZN","LU0823416689.USD","BK4533","BK4532","IE00BN0W2T93.GBP","LU2236285917.USD","LU0320765992.SGD","IE00BN0W2V16.EUR","KRYS","LU2456880835.USD","LU2417539215.USD","BK4568","LU0889565916.HKD","LU1829250122.USD","BK4585","DVAX","LU0109394709.USD","BK4156","JAZZ","BK4007","BK4139","BK4588","LU2462157665.USD","IE00BN0W2W23.USD"],"gpt_icon":0},{"id":"2525734293","title":"AMGN's Uplizna Gets FDA Nod for 2nd Rare Autoimmune Disease Indication","url":"https://stock-news.laohu8.com/highlight/detail?id=2525734293","media":"Zacks","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2525734293?lang=en_us&edition=fundamental","pubTime":"2025-04-05 01:10","pubTimestamp":1743786600,"startTime":"0","endTime":"0","summary":"Amgen AMGN announced that the FDA has approved its rare disease drug Uplizna  for a new indication. The regulatory body has now approved Uplizna for the treatment of adults living with immunoglobulin G4-related disease , a rare immune-mediated inflammatory condition. This marks the second approved indication for the drug.Uplizna is currently approved in the United States for treating adults with a rare autoimmune disease called neuromyelitis optica spectrum disorder.Following the nod, Uplizna became the first and only drug approved by the FDA for the treatment of IgG4-RD, a chronic disease with a significant unmet medical need.The FDA had previously granted a breakthrough therapy designation to Uplizna for the treatment of IgG4-RD.Year to date, shares of Amgen have rallied 18.9% compared with the industry’s rise of 1.2%.Uplizna's Nod for IgG4-RD Based on AMGN's MITIGATE Study. Some better-ranked stocks in the biotech sector are Jazz Pharmaceuticals, Inc. JAZZ, Dynavax Technologies Corp","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/amgns-uplizna-gets-fda-nod-171000251.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4566","KRYS","LU1057294990.SGD","LU2242646821.SGD","BK4534","SG9999001440.SGD","IE00BN0W2W23.USD","LU2112291526.USD","LU0109394709.USD","IE00BN0W2T93.GBP","BK4139","BK4533","LU2089984988.USD","IE00BN0W2V16.EUR","LU0289739699.SGD","LU0889565916.HKD","LU1571399168.USD","IE00BJT1NW94.SGD","LU0868494617.USD","LU1983299246.USD","LU0320765992.SGD","IE00B4R5TH58.HKD","IE0002141913.USD","IE00BJJMRZ35.SGD","BK4532","IE0009355771.USD","BK4588","BK4007","LU0122379950.USD","LU2242652126.USD","LU2468319806.SGD","JAZZ","IE00BFTCPJ56.SGD","BK4585","LU0823416689.USD","LU1023059063.AUD","LU1061106388.HKD","BK4599","AMGN","DVAX","IE00B2B36J28.USD","LU0058720904.USD","BK4581"],"gpt_icon":0},{"id":"2524296191","title":"SNY's Rilzabrutinib Gets FDA's Orphan Drug Tag for Two Rare Diseases","url":"https://stock-news.laohu8.com/highlight/detail?id=2524296191","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524296191?lang=en_us&edition=fundamental","pubTime":"2025-04-03 23:27","pubTimestamp":1743694020,"startTime":"0","endTime":"0","summary":"Sanofi SNY announced that the FDA has granted orphan drug designation to its investigational BTK inhibitor, rilzabrutinib, for the treatment of warm autoimmune hemolytic anemia  and IgG4-related disease .The candidate is being developed in separate mid-stage studies for treating wAIHA and IgG4-RD, two rare diseases.Currently, there are no approved therapies for treating wAIHA and IgG4-RD. Both diseases have a significant unmet medical need.The FDA grants orphan drug designation to support the development of medicines for rare disorders that affect less than 200,000 patients in the United States.Sanofi has developed rilzabrutinib for treating immune thrombocytopenia , another rare, complex autoimmune disorder.A regulatory application seeking approval for rilzabrutinib for treating ITP is currently under review in the United States. A final decision from the FDA is expected on Aug. 29, 2025. The regulatory body has previously granted a fast-track designation and an orphan drug designatio","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/snys-rilzabrutinib-gets-fdas-orphan-152700727.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU0823416689.USD","JAZZ","DVAX","BK4585","BK4532","BK4533","IE00BN0W2V16.EUR","BK4139","BK4588","IE00BFXG1179.USD","KRYS","LU0109394709.USD","BK4007","LU0320765992.SGD","LU0889565916.HKD","SNY","IE00BN0W2T93.GBP","IE00BN0W2W23.USD"],"gpt_icon":0},{"id":"2524423495","title":"William Blair Keeps Their Buy Rating on Krystal Biotech (KRYS)","url":"https://stock-news.laohu8.com/highlight/detail?id=2524423495","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524423495?lang=en_us&edition=fundamental","pubTime":"2025-04-03 18:18","pubTimestamp":1743675480,"startTime":"0","endTime":"0","summary":"In a report released today, Sami Corwin from William Blair maintained a Buy rating on Krystal Biotech (KRYS – Research Report). The company’s share...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/william-blair-keeps-their-buy-rating-on-krystal-biotech-krys-2?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate","earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/william-blair-keeps-their-buy-rating-on-krystal-biotech-krys-2?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["KRYS"],"gpt_icon":0},{"id":"2524416973","title":"Alkermes Begins Idiopathic Hypersomnia Study on ALKS 2680","url":"https://stock-news.laohu8.com/highlight/detail?id=2524416973","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524416973?lang=en_us&edition=fundamental","pubTime":"2025-04-02 21:33","pubTimestamp":1743600780,"startTime":"0","endTime":"0","summary":"Alkermes plc ALKS announced that it has initiated the phase II Vibrance-3 study, evaluating the novel, investigational and oral orexin 2 receptor agonist, ALKS 2680, in adults with idiopathic hypersomnia , a rare, chronic and neurological sleep disorder.The double-blind, placebo-controlled study will evaluate the safety and efficacy of ALKS 2680 compared with placebo in adults with IH. The primary endpoint of the Vibrance-3 study will check, by dose level, whether treatment with ALKS 2680 leads to a greater decrease in sleepiness versus placebo alone, as measured by the change in Epworth Sleepiness Scale score.In the study, participants will be randomized to receive one of the three doses of ALKS 2680  or placebo to be taken once daily for eight weeks.Secondary endpoints of the Vibrance-3 study are changes in the Idiopathic Hypersomnia Severity Scale score and incidence of adverse events.Besides IH, ALKS 2680 is also being developed for the treatment of narcolepsy type 1 and type 2.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/alkermes-begins-idiopathic-hypersomnia-study-133300611.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["IE00BN0W2T93.GBP","ALKS","IE00BN0W2V16.EUR","BK4139","BK4532","KRYS","LU0109394709.USD","LU0823416689.USD","BK4007","LU0889565916.HKD","IE00BN0W2W23.USD","BK4585","BK4505","JAZZ","AXSM","LU0320765992.SGD","BK4533"],"gpt_icon":0},{"id":"2524449231","title":"VRTX Provides Mixed Updates for Type 1 Diabetes Pipeline Candidates","url":"https://stock-news.laohu8.com/highlight/detail?id=2524449231","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524449231?lang=en_us&edition=fundamental","pubTime":"2025-04-01 22:55","pubTimestamp":1743519300,"startTime":"0","endTime":"0","summary":"Vertex Pharmaceuticals Incorporated VRTX announced updates on its two novel investigational candidates, zimislecel  and VX-264, which are being developed in separate studies for the treatment of type 1 diabetes .Zimislecel is designed for the transplantation of islet cells alone, using immunosuppression to protect the implanted cells. The candidate is in pivotal late-stage development for treating patients with T1D with severe hypoglycemic events  and impaired awareness of hypoglycemia.Meanwhile, VX-264 is being developed following a unique approach that involves the implantation of the islet cells inside an immunoprotective device.Year to date, shares of Vertex have rallied 20.4% compared with the industry’s rise of 3.5%.In the past 60 days, estimates for Jazz Pharmaceuticals’ earnings per share have increased from $22.06 to $23.33 for 2025. During the same time, earnings per share estimates for 2026 have increased from $23.13 to $23.35. Year to date, shares of JAZZ have risen 0.8%.In","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/vrtx-provides-mixed-updates-type-145500721.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["DVAX","IE00B2B36J28.USD","BK4533","IE00BZ9MQY76.HKD","BK4588","BK4023","LU2362540622.SGD","BK4007","IE00B4R5TH58.HKD","IE0009355771.USD","LU2456880835.USD","LU2462157665.USD","VRTX","BK4567","IE00B19Z9Z06.USD","LU2362541273.HKD","LU2417539215.USD","VERX","BK4532","IE00B19Z3B42.SGD","IE00BFTCPJ56.SGD","IE00BN0W2V16.EUR","LU0757428866.USD","LU2236285917.USD","JAZZ","LU0234570918.USD","LU1069344957.HKD","LU0823416689.USD","LU0256863811.USD","LU1093756325.SGD","LU0058720904.USD","LU1815336091.USD","LU1585245621.USD","IE00B19Z3581.USD","IE00BN0W2T93.GBP","LU0109394709.USD","IE00B19Z9P08.USD","IE00BJT1NW94.SGD","LU1093756168.USD","KRYS","LU0320765992.SGD","LU2237438978.USD","LU2362541513.USD","IE00BJJMRZ35.SGD","LU2324357040.USD","IE0002141913.USD","LU1430594728.SGD","IE00BN0W2W23.USD","LU1035775433.USD","LU0566484027.USD"],"gpt_icon":0},{"id":"2523685645","title":"Mirum Pharmaceuticals (MIRM) Down 1.9% Since Last Earnings Report: Can It Rebound?","url":"https://stock-news.laohu8.com/highlight/detail?id=2523685645","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2523685645?lang=en_us&edition=fundamental","pubTime":"2025-03-28 23:30","pubTimestamp":1743175846,"startTime":"0","endTime":"0","summary":"It has been about a month since the last earnings report for Mirum Pharmaceuticals, Inc. . Shares have lost about 1.9% in that time frame, outperforming the S&P 500.Will the recent negative trend continue leading up to its next earnings release, or is Mirum Pharmaceuticals due for a breakout?Before we dive into how investors and analysts have reacted as of late, let's take a quick look at its most recent earnings report in order to get a better handle on the important catalysts.It turns out, fresh estimates have trended downward during the past month.The consensus estimate has shifted -71.77% due to these changes.Mirum Pharmaceuticals is part of the Zacks Medical - Biomedical and Genetics industry. Over the past month, Krystal Biotech, Inc. , a stock from the same industry, has gained 5.4%. The company reported its results for the quarter ended December 2024 more than a month ago.Krystal Biotech, Inc.  : Free Stock Analysis Report. This article originally published on Zacks Investment ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/mirum-pharmaceuticals-mirm-down-1-153046784.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["MIRM","KRYS"],"gpt_icon":0}],"pageSize":20,"totalPage":6,"pageCount":3,"totalSize":112,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/KRYS\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-05-06","symbol":"KRYS","fiscalQuarterEnding":"2025/03","expectedEps":1.38,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1746504000000,"reportTimeType":"pre","actualEps":1.2},{"market":"US","date":"2025-02-19","symbol":"KRYS","fiscalQuarterEnding":"2024/12","expectedEps":1.29,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1739941200000,"reportTimeType":"pre","actualEps":1.52},{"market":"US","date":"2024-11-04","symbol":"KRYS","fiscalQuarterEnding":"2024/09","expectedEps":0.84,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1730696400000,"reportTimeType":"pre","actualEps":0.91},{"market":"US","date":"2024-08-05","symbol":"KRYS","fiscalQuarterEnding":"2024/06","expectedEps":0.5,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1722830400000,"reportTimeType":"pre","actualEps":0.86},{"market":"US","date":"2024-05-06","symbol":"KRYS","fiscalQuarterEnding":"2024/03","expectedEps":0.2,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1714968000000,"reportTimeType":"pre","actualEps":0.03}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"KRYS\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"KRYS\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.3636,"buy":0.5455,"hold":0.0909,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.5455,"analysts":11,"updateTime":1741320000000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/KRYS\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"KRYS","date":"2025-07-17","current":34.988011,"percent":0.766116,"low":-123.95382,"twenty":-38.949071,"median":-20.356335,"eighty":50.427923,"high":470.599576,"avg":7.831711,"sd":100.357858,"marketCap":4337113894},"quantilePoints":[{"date":"2020-07-24","current":-40.622146,"twenty":-48.763993,"median":-38.461963,"eighty":-15.464029,"marketCap":825360761},{"date":"2020-07-31","current":-39.954464,"twenty":-48.569177,"median":-38.50116,"eighty":-15.518253,"marketCap":811794803},{"date":"2020-08-07","current":-38.619101,"twenty":-48.484625,"median":-38.628777,"eighty":-15.533326,"marketCap":784662887},{"date":"2020-08-14","current":-38.42081,"twenty":-48.460798,"median":-38.50116,"eighty":-15.561678,"marketCap":837688913},{"date":"2020-08-21","current":-42.434251,"twenty":-48.402681,"median":-38.628777,"eighty":-15.619545,"marketCap":925193975},{"date":"2020-08-28","current":-42.289948,"twenty":-48.316277,"median":-38.776134,"eighty":-15.632374,"marketCap":922047726},{"date":"2020-09-04","current":-38.231411,"twenty":-48.16771,"median":-38.907924,"eighty":-15.632374,"marketCap":833559461},{"date":"2020-09-11","current":-39.304669,"twenty":-48.037322,"median":-38.992067,"eighty":-15.635454,"marketCap":856959691},{"date":"2020-09-18","current":-43.732983,"twenty":-47.960406,"median":-39.127596,"eighty":-15.720644,"marketCap":953510220},{"date":"2020-09-25","current":-37.329514,"twenty":-47.873041,"median":-39.043119,"eighty":-15.799665,"marketCap":813895402},{"date":"2020-10-02","current":-38.925872,"twenty":-47.813488,"median":-39.010856,"eighty":-15.815397,"marketCap":848700786},{"date":"2020-10-09","current":-45.726175,"twenty":-47.799138,"median":-39.094839,"eighty":-15.821857,"marketCap":996967791},{"date":"2020-10-16","current":-46.55592,"twenty":-47.60037,"median":-39.181647,"eighty":-15.914872,"marketCap":1015058725},{"date":"2020-10-23","current":-43.426338,"twenty":-47.432166,"median":-39.194011,"eighty":-15.995117,"marketCap":946824440},{"date":"2020-10-30","current":-38.772549,"twenty":-47.386871,"median":-39.194011,"eighty":-16.023711,"marketCap":845357896},{"date":"2020-11-06","current":-36.653092,"twenty":-47.354955,"median":-39.194011,"eighty":-16.063086,"marketCap":799147357},{"date":"2020-11-13","current":-30.409901,"twenty":-47.170996,"median":-39.181647,"eighty":-16.088818,"marketCap":825355125},{"date":"2020-11-20","current":-30.656782,"twenty":-47.038907,"median":-39.160354,"eighty":-16.102159,"marketCap":832055716},{"date":"2020-11-27","current":-35.478218,"twenty":-46.988589,"median":-39.043119,"eighty":-16.111788,"marketCap":962914313},{"date":"2020-12-04","current":-41.054819,"twenty":-46.909261,"median":-39.036382,"eighty":-16.155606,"marketCap":1114268834},{"date":"2020-12-11","current":-42.390879,"twenty":-46.831104,"median":-39.160354,"eighty":-16.218049,"marketCap":1150530855},{"date":"2020-12-18","current":-42.550626,"twenty":-46.74103,"median":-39.181647,"eighty":-16.22724,"marketCap":1154866532},{"date":"2020-12-24","current":-43.966559,"twenty":-46.706201,"median":-39.194011,"eighty":-16.239255,"marketCap":1193296391},{"date":"2020-12-31","current":-43.567194,"twenty":-46.700839,"median":-39.194011,"eighty":-16.270926,"marketCap":1182457200},{"date":"2021-01-08","current":-48.163532,"twenty":-46.707542,"median":-39.222093,"eighty":-16.330309,"marketCap":1307206434},{"date":"2021-01-15","current":-49.267235,"twenty":-47.026811,"median":-39.312778,"eighty":-16.350103,"marketCap":1337162017},{"date":"2021-01-22","current":-51.685214,"twenty":-47.348436,"median":-39.331739,"eighty":-16.350103,"marketCap":1402788391},{"date":"2021-01-29","current":-50.610557,"twenty":-47.536338,"median":-39.429613,"eighty":-16.358021,"marketCap":1373621114},{"date":"2021-02-05","current":-55.692316,"twenty":-47.956498,"median":-39.469045,"eighty":-16.407506,"marketCap":1511545135},{"date":"2021-02-12","current":-56.604907,"twenty":-48.164984,"median":-39.530585,"eighty":-16.427129,"marketCap":1536313784},{"date":"2021-02-19","current":-62.169293,"twenty":-48.334455,"median":-39.547414,"eighty":-16.429194,"marketCap":1687336782},{"date":"2021-02-26","current":-63.711815,"twenty":-48.612075,"median":-39.591594,"eighty":-16.453033,"marketCap":1729202374},{"date":"2021-03-05","current":-50.189519,"twenty":-48.904406,"median":-39.639652,"eighty":-16.486684,"marketCap":1614446260},{"date":"2021-03-12","current":-57.137669,"twenty":-49.133564,"median":-39.830718,"eighty":-16.53419,"marketCap":1837947413},{"date":"2021-03-19","current":-52.825262,"twenty":-49.623845,"median":-39.893027,"eighty":-16.56982,"marketCap":1699230213},{"date":"2021-03-26","current":-47.567576,"twenty":-49.68696,"median":-39.940721,"eighty":-16.613367,"marketCap":1530106202},{"date":"2021-04-01","current":-52.93566,"twenty":-49.847846,"median":-39.966136,"eighty":-16.664832,"marketCap":1702781373},{"date":"2021-04-09","current":-47.830083,"twenty":-50.030354,"median":-40.035446,"eighty":-16.752651,"marketCap":1538550290},{"date":"2021-04-16","current":-53.380002,"twenty":-50.15676,"median":-40.066266,"eighty":-16.823283,"marketCap":1717074526},{"date":"2021-04-23","current":-54.23596,"twenty":-50.298536,"median":-40.105351,"eighty":-16.829126,"marketCap":1744608114},{"date":"2021-04-30","current":-54.836511,"twenty":-50.568713,"median":-40.195749,"eighty":-16.896599,"marketCap":1763926036},{"date":"2021-05-07","current":-48.858613,"twenty":-50.598152,"median":-40.212064,"eighty":-17.001821,"marketCap":1571635005},{"date":"2021-05-14","current":-35.375963,"twenty":-50.568713,"median":-40.195749,"eighty":-17.053635,"marketCap":1508360312},{"date":"2021-05-21","current":-34.162567,"twenty":-50.539339,"median":-40.105351,"eighty":-17.121529,"marketCap":1456623531},{"date":"2021-05-28","current":-33.975089,"twenty":-50.518252,"median":-40.066266,"eighty":-17.249917,"marketCap":1448629865},{"date":"2021-06-04","current":-32.397154,"twenty":-50.477052,"median":-40.0385,"eighty":-17.413058,"marketCap":1381349845},{"date":"2021-06-11","current":-33.876143,"twenty":-50.309576,"median":-39.968131,"eighty":-17.504112,"marketCap":1444410986},{"date":"2021-06-18","current":-34.006336,"twenty":-50.254427,"median":-39.940721,"eighty":-17.654488,"marketCap":1449962143},{"date":"2021-06-25","current":-35.240563,"twenty":-50.206276,"median":-39.893027,"eighty":-17.686971,"marketCap":1502587109},{"date":"2021-07-02","current":-36.453959,"twenty":-50.188044,"median":-39.830718,"eighty":-17.69498,"marketCap":1554323890},{"date":"2021-07-09","current":-35.870695,"twenty":-50.182146,"median":-39.724691,"eighty":-17.71023,"marketCap":1529454707},{"date":"2021-07-16","current":-33.105402,"twenty":-50.118681,"median":-39.615785,"eighty":-17.725808,"marketCap":1411548138},{"date":"2021-07-23","current":-31.558713,"twenty":-50.051444,"median":-39.555828,"eighty":-17.745602,"marketCap":1345600396},{"date":"2021-07-30","current":-30.433848,"twenty":-49.99872,"median":-39.530585,"eighty":-17.817891,"marketCap":1297638401},{"date":"2021-08-06","current":-31.194173,"twenty":-49.938822,"median":-39.469045,"eighty":-17.874265,"marketCap":1330057157},{"date":"2021-08-13","current":-23.913834,"twenty":-49.883576,"median":-39.429613,"eighty":-17.90402,"marketCap":1247512967},{"date":"2021-08-20","current":-22.68792,"twenty":-49.79425,"median":-39.331739,"eighty":-17.925552,"marketCap":1183560718},{"date":"2021-08-27","current":-24.688543,"twenty":-49.74713,"median":-39.304669,"eighty":-18.366962,"marketCap":1287927236},{"date":"2021-09-03","current":-24.931172,"twenty":-49.646847,"median":-39.216466,"eighty":-18.388495,"marketCap":1300584451},{"date":"2021-09-10","current":-24.688543,"twenty":-49.616178,"median":-39.194011,"eighty":-18.431559,"marketCap":1287927236},{"date":"2021-09-17","current":-25.195084,"twenty":-49.605002,"median":-39.194011,"eighty":-18.588744,"marketCap":1314351949},{"date":"2021-09-24","current":-23.960657,"twenty":-49.526812,"median":-39.170024,"eighty":-18.649982,"marketCap":1249955588},{"date":"2021-10-01","current":-22.939062,"twenty":-49.451445,"median":-39.094839,"eighty":-18.803765,"marketCap":1196662047},{"date":"2021-10-08","current":-21.96429,"twenty":-49.301275,"median":-39.010856,"eighty":-19.133337,"marketCap":1145811127},{"date":"2021-10-15","current":-20.738376,"twenty":-49.204717,"median":-38.949071,"eighty":-19.258353,"marketCap":1081858878},{"date":"2021-10-22","current":-23.117841,"twenty":-49.133851,"median":-38.916338,"eighty":-19.357444,"marketCap":1205988417},{"date":"2021-10-29","current":-21.321537,"twenty":-49.101247,"median":-38.817644,"eighty":-19.544974,"marketCap":1112280607},{"date":"2021-11-05","current":-21.840847,"twenty":-49.044258,"median":-38.756093,"eighty":-19.7047,"marketCap":1139371491},{"date":"2021-11-12","current":-18.1661,"twenty":-48.981858,"median":-38.628777,"eighty":-19.142222,"marketCap":1056304240},{"date":"2021-11-19","current":-20.028604,"twenty":-48.927861,"median":-38.546893,"eighty":-18.827374,"marketCap":1164603222},{"date":"2021-11-26","current":-15.225104,"twenty":-48.904406,"median":-38.463296,"eighty":-18.643824,"marketCap":885294143},{"date":"2021-12-03","current":-29.173669,"twenty":-48.882674,"median":-38.43672,"eighty":-18.726968,"marketCap":1696361350},{"date":"2021-12-10","current":-30.64713,"twenty":-48.864761,"median":-38.327334,"eighty":-18.774187,"marketCap":1782038681},{"date":"2021-12-17","current":-30.831313,"twenty":-48.857578,"median":-38.211464,"eighty":-18.814077,"marketCap":1792748347},{"date":"2021-12-23","current":-30.981229,"twenty":-48.81044,"median":-38.116975,"eighty":-18.858441,"marketCap":1801465518},{"date":"2021-12-31","current":-29.9618,"twenty":-48.685744,"median":-38.062665,"eighty":-18.99677,"marketCap":1742188759},{"date":"2022-01-07","current":-27.503176,"twenty":-48.572435,"median":-38.016003,"eighty":-19.181169,"marketCap":1599227166},{"date":"2022-01-14","current":-26.676496,"twenty":-48.505452,"median":-37.928,"eighty":-19.232428,"marketCap":1551158198},{"date":"2022-01-21","current":-23.682457,"twenty":-48.470858,"median":-37.86578,"eighty":-19.292847,"marketCap":1377063853},{"date":"2022-01-28","current":-23.02711,"twenty":-48.443754,"median":-37.79723,"eighty":-19.420475,"marketCap":1338957365},{"date":"2022-02-04","current":-24.367788,"twenty":-48.384784,"median":-37.713725,"eighty":-19.61603,"marketCap":1416913774},{"date":"2022-02-11","current":-27.858691,"twenty":-48.353986,"median":-37.628943,"eighty":-19.746268,"marketCap":1619899313},{"date":"2022-02-18","current":-26.068265,"twenty":-48.294422,"median":-37.527971,"eighty":-19.799528,"marketCap":1515791392},{"date":"2022-02-25","current":-26.770729,"twenty":-48.279712,"median":-37.476042,"eighty":-19.820386,"marketCap":1556637562},{"date":"2022-03-04","current":-20.780274,"twenty":-48.170794,"median":-37.375723,"eighty":-19.874216,"marketCap":1445683674},{"date":"2022-03-11","current":-23.490587,"twenty":-48.163532,"median":-37.319356,"eighty":-20.028604,"marketCap":1634240150},{"date":"2022-03-18","current":-25.686376,"twenty":-48.135113,"median":-37.241884,"eighty":-20.040286,"marketCap":1787001145},{"date":"2022-03-25","current":-23.316663,"twenty":-48.134488,"median":-37.20653,"eighty":-20.244009,"marketCap":1622140269},{"date":"2022-04-01","current":-25.671882,"twenty":-47.972128,"median":-37.140116,"eighty":-20.291429,"marketCap":1785992822},{"date":"2022-04-08","current":-24.639209,"twenty":-47.952591,"median":-36.813313,"eighty":-20.447526,"marketCap":1714149780},{"date":"2022-04-14","current":-26.266122,"twenty":-47.854585,"median":-36.709334,"eighty":-20.591978,"marketCap":1827334081},{"date":"2022-04-22","current":-25.113876,"twenty":-47.822023,"median":-36.538643,"eighty":-20.716319,"marketCap":1747172371},{"date":"2022-04-29","current":-21.961507,"twenty":-47.811315,"median":-36.49065,"eighty":-20.771894,"marketCap":1527862031},{"date":"2022-05-06","current":-20.356335,"twenty":-47.795803,"median":-36.453959,"eighty":-20.771894,"marketCap":1416190215},{"date":"2022-05-13","current":-13.934316,"twenty":-47.750551,"median":-36.327794,"eighty":-20.343354,"marketCap":1445309080},{"date":"2022-05-20","current":-14.591735,"twenty":-47.740072,"median":-36.233637,"eighty":-19.997726,"marketCap":1513498547},{"date":"2022-05-27","current":-14.893258,"twenty":-47.602075,"median":-36.204791,"eighty":-19.7047,"marketCap":1544773415},{"date":"2022-06-03","current":-15.310942,"twenty":-47.510413,"median":-36.177424,"eighty":-19.24539,"marketCap":1588096799},{"date":"2022-06-10","current":-13.810741,"twenty":-47.432166,"median":-36.136288,"eighty":-18.814077,"marketCap":1432491511},{"date":"2022-06-17","current":-13.716824,"twenty":-47.389756,"median":-36.049958,"eighty":-18.612985,"marketCap":1422750159},{"date":"2022-06-24","current":-16.934717,"twenty":-47.377399,"median":-35.980519,"eighty":-18.375575,"marketCap":1756519655},{"date":"2022-07-01","current":-16.67521,"twenty":-47.361475,"median":-35.968421,"eighty":-18.014122,"marketCap":1729602760},{"date":"2022-07-08","current":-18.064192,"twenty":-47.320353,"median":-35.870695,"eighty":-17.922179,"marketCap":1873672236},{"date":"2022-07-15","current":-17.898602,"twenty":-47.198689,"median":-35.678732,"eighty":-17.879132,"marketCap":1856496693},{"date":"2022-07-22","current":-17.298028,"twenty":-47.051002,"median":-35.584271,"eighty":-17.828596,"marketCap":1794203308},{"date":"2022-07-29","current":-17.938146,"twenty":-47.0077,"median":-35.480795,"eighty":-17.817212,"marketCap":1860598316},{"date":"2022-08-05","current":-20.288542,"twenty":-46.920258,"median":-35.417625,"eighty":-17.801224,"marketCap":2104388478},{"date":"2022-08-12","current":-17.625319,"twenty":-46.853686,"median":-35.366012,"eighty":-17.729767,"marketCap":2035177959},{"date":"2022-08-19","current":-16.951867,"twenty":-46.752193,"median":-35.323413,"eighty":-17.686971,"marketCap":1957415169},{"date":"2022-08-26","current":-15.629413,"twenty":-46.706201,"median":-35.308589,"eighty":-17.612613,"marketCap":1804712661},{"date":"2022-09-02","current":-15.718317,"twenty":-46.676374,"median":-35.240563,"eighty":-17.403682,"marketCap":1814978376},{"date":"2022-09-09","current":-15.744989,"twenty":-46.578516,"median":-35.087812,"eighty":-17.243655,"marketCap":1818058091},{"date":"2022-09-16","current":-15.229342,"twenty":-46.557824,"median":-35.036637,"eighty":-17.102287,"marketCap":1758516945},{"date":"2022-09-23","current":-15.044866,"twenty":-46.55592,"median":-35.010504,"eighty":-16.988902,"marketCap":1737215587},{"date":"2022-09-30","current":-15.491611,"twenty":-46.49581,"median":-34.885868,"eighty":-16.891857,"marketCap":1788800803},{"date":"2022-10-07","current":-14.707028,"twenty":-46.461793,"median":-34.834361,"eighty":-16.822027,"marketCap":1698205870},{"date":"2022-10-14","current":-14.671467,"twenty":-46.418331,"median":-34.793122,"eighty":-16.63712,"marketCap":1694099584},{"date":"2022-10-21","current":-15.502724,"twenty":-46.353136,"median":-34.700752,"eighty":-16.49856,"marketCap":1790084018},{"date":"2022-10-28","current":-17.287482,"twenty":-46.309342,"median":-34.636468,"eighty":-16.468869,"marketCap":1996168242},{"date":"2022-11-04","current":-16.271748,"twenty":-46.234543,"median":-34.582951,"eighty":-16.431776,"marketCap":1878882451},{"date":"2022-11-11","current":-15.210937,"twenty":-46.168419,"median":-34.435035,"eighty":-16.368613,"marketCap":1973299666},{"date":"2022-11-18","current":-15.355822,"twenty":-46.157554,"median":-34.313591,"eighty":-16.330309,"marketCap":1992095448},{"date":"2022-11-25","current":-15.62376,"twenty":-46.086628,"median":-34.283013,"eighty":-16.267534,"marketCap":2026854771},{"date":"2022-12-02","current":-15.381624,"twenty":-46.063708,"median":-34.2247,"eighty":-16.23032,"marketCap":1995442642},{"date":"2022-12-09","current":-14.097506,"twenty":-46.034552,"median":-34.199021,"eighty":-16.194819,"marketCap":1828855366},{"date":"2022-12-16","current":-15.846049,"twenty":-46.009864,"median":-34.117009,"eighty":-16.105287,"marketCap":2055692136},{"date":"2022-12-23","current":-15.208952,"twenty":-45.976836,"median":-34.094867,"eighty":-16.032251,"marketCap":1973042189},{"date":"2022-12-30","current":-15.722996,"twenty":-45.957195,"median":-34.006336,"eighty":-15.997799,"marketCap":2039728595},{"date":"2023-01-06","current":-16.445436,"twenty":-45.957195,"median":-34.006336,"eighty":-16.026688,"marketCap":2133450030},{"date":"2023-01-13","current":-16.463299,"twenty":-45.957195,"median":-34.006336,"eighty":-16.052385,"marketCap":2135767318},{"date":"2023-01-20","current":-16.121926,"twenty":-45.957195,"median":-34.006336,"eighty":-16.075746,"marketCap":2091481365},{"date":"2023-01-27","current":-16.715359,"twenty":-45.957195,"median":-34.006336,"eighty":-16.115059,"marketCap":2168466830},{"date":"2023-02-03","current":-15.919484,"twenty":-45.957195,"median":-34.006336,"eighty":-16.177016,"marketCap":2065218765},{"date":"2023-02-10","current":-15.238723,"twenty":-45.957195,"median":-34.006336,"eighty":-16.177016,"marketCap":1976904336},{"date":"2023-02-17","current":-15.530478,"twenty":-45.957195,"median":-34.006336,"eighty":-16.177016,"marketCap":2014753377},{"date":"2023-02-24","current":-15.572157,"twenty":-45.957195,"median":-34.006336,"eighty":-16.177016,"marketCap":2020160383},{"date":"2023-03-03","current":-14.548071,"twenty":-45.957195,"median":-34.006336,"eighty":-16.177016,"marketCap":2036366246},{"date":"2023-03-10","current":-13.465801,"twenty":-45.957195,"median":-34.006336,"eighty":-16.177016,"marketCap":1884875437},{"date":"2023-03-17","current":-13.684832,"twenty":-45.957195,"median":-34.006336,"eighty":-16.177016,"marketCap":1915534292},{"date":"2023-03-24","current":-14.336403,"twenty":-45.957195,"median":-34.006336,"eighty":-16.177016,"marketCap":2006737942},{"date":"2023-03-31","current":-14.735812,"twenty":-45.953031,"median":-33.990713,"eighty":-16.121365,"marketCap":2062645264},{"date":"2023-04-06","current":-14.458549,"twenty":-45.953031,"median":-33.990713,"eighty":-16.121365,"marketCap":2023835412},{"date":"2023-04-14","current":-16.381934,"twenty":-45.957195,"median":-34.006336,"eighty":-16.215813,"marketCap":2293061223},{"date":"2023-04-21","current":-16.077951,"twenty":-45.957195,"median":-34.006336,"eighty":-16.227249,"marketCap":2250511167},{"date":"2023-04-28","current":-15.451561,"twenty":-45.957195,"median":-34.006336,"eighty":-16.227249,"marketCap":2162832263},{"date":"2023-05-05","current":-15.140209,"twenty":-45.957195,"median":-34.006336,"eighty":-16.227249,"marketCap":2119250690},{"date":"2023-05-12","current":-17.21991,"twenty":-45.957195,"median":-34.006336,"eighty":-16.238247,"marketCap":2329974338},{"date":"2023-05-19","current":-16.674578,"twenty":-45.976836,"median":-34.094867,"eighty":-16.310866,"marketCap":2256187088},{"date":"2023-05-24","current":-24.238106,"twenty":-45.983985,"median":-34.102678,"eighty":-16.350103,"marketCap":3279585403},{"date":"2023-06-23","current":-24.404943,"twenty":-46.067599,"median":-34.263206,"eighty":-16.497343,"marketCap":3302159566},{"date":"2023-06-30","current":-23.534137,"twenty":-46.068896,"median":-34.273109,"eighty":-16.557943,"marketCap":3184333447},{"date":"2023-07-07","current":-24.687751,"twenty":-46.068896,"median":-34.273109,"eighty":-16.674578,"marketCap":3340425525},{"date":"2023-07-14","current":-25.51583,"twenty":-46.068896,"median":-34.273109,"eighty":-16.67521,"marketCap":3452470456},{"date":"2023-07-21","current":-25.447272,"twenty":-46.068896,"median":-34.273109,"eighty":-16.67521,"marketCap":3443194084},{"date":"2023-07-28","current":-25.0364,"twenty":-46.068896,"median":-34.273109,"eighty":-16.67521,"marketCap":3387600119},{"date":"2023-08-04","current":-25.721876,"twenty":-46.068896,"median":-34.273109,"eighty":-16.67521,"marketCap":3480349850},{"date":"2023-08-11","current":-24.078633,"twenty":-46.068896,"median":-34.273109,"eighty":-16.793842,"marketCap":3380856756},{"date":"2023-08-18","current":-23.486486,"twenty":-46.068896,"median":-34.273109,"eighty":-16.891857,"marketCap":3297714050},{"date":"2023-08-25","current":-24.754517,"twenty":-46.068896,"median":-34.273109,"eighty":-17.009655,"marketCap":3475757016},{"date":"2023-09-01","current":-24.818318,"twenty":-46.068896,"median":-34.273109,"eighty":-17.21991,"marketCap":3484715152},{"date":"2023-09-08","current":-24.162371,"twenty":-46.068896,"median":-34.273109,"eighty":-17.243655,"marketCap":3392614310},{"date":"2023-09-15","current":-23.725737,"twenty":-46.068896,"median":-34.273109,"eighty":-17.287482,"marketCap":3331307063},{"date":"2023-09-22","current":-23.679881,"twenty":-46.068896,"median":-34.273109,"eighty":-17.468482,"marketCap":3324868402},{"date":"2023-09-29","current":-23.506424,"twenty":-46.068896,"median":-34.273109,"eighty":-17.574836,"marketCap":3300513468},{"date":"2023-10-06","current":-22.872408,"twenty":-46.068896,"median":-34.273109,"eighty":-17.725597,"marketCap":3211491985},{"date":"2023-10-13","current":-22.100823,"twenty":-46.068896,"median":-34.273109,"eighty":-17.898602,"marketCap":3103154520},{"date":"2023-10-20","current":-21.931354,"twenty":-46.068896,"median":-34.273109,"eighty":-17.898602,"marketCap":3079359470},{"date":"2023-10-27","current":-23.528355,"twenty":-46.122091,"median":-34.313591,"eighty":-17.88229,"marketCap":3303592827},{"date":"2023-11-03","current":-23.735706,"twenty":-46.122091,"median":-34.313591,"eighty":-17.88229,"marketCap":3332706771},{"date":"2023-11-10","current":-90.829454,"twenty":-46.392253,"median":-34.313591,"eighty":-17.88229,"marketCap":2707807680},{"date":"2023-11-17","current":-93.043422,"twenty":-46.570239,"median":-34.313591,"eighty":-17.88229,"marketCap":2773810492},{"date":"2023-11-24","current":-97.329437,"twenty":-46.831104,"median":-34.313591,"eighty":-17.88229,"marketCap":2901585167},{"date":"2023-12-01","current":-98.616187,"twenty":-47.298789,"median":-34.313591,"eighty":-17.88229,"marketCap":2939945775},{"date":"2023-12-08","current":-97.830891,"twenty":-47.510413,"median":-34.313591,"eighty":-17.887727,"marketCap":2916534522},{"date":"2023-12-15","current":-110.017176,"twenty":-47.813488,"median":-34.313591,"eighty":-17.887727,"marketCap":3279832052},{"date":"2023-12-22","current":-110.471323,"twenty":-48.134738,"median":-34.371057,"eighty":-17.887727,"marketCap":3293371090},{"date":"2023-12-29","current":-120.878865,"twenty":-48.236145,"median":-34.428523,"eighty":-17.88229,"marketCap":3603640720},{"date":"2024-01-05","current":-113.659816,"twenty":-48.384784,"median":-34.371057,"eighty":-17.876852,"marketCap":3388426422},{"date":"2024-01-12","current":-118.295902,"twenty":-48.713256,"median":-34.371057,"eighty":-17.876852,"marketCap":3526637439},{"date":"2024-01-19","current":-121.635777,"twenty":-48.895713,"median":-34.313591,"eighty":-17.871415,"marketCap":3626205784},{"date":"2024-01-26","current":-114.189654,"twenty":-49.115343,"median":-34.371057,"eighty":-17.876852,"marketCap":3404221967},{"date":"2024-02-02","current":-105.551395,"twenty":-49.584797,"median":-34.371057,"eighty":-17.876852,"marketCap":3146698174},{"date":"2024-02-09","current":-105.04994,"twenty":-49.865711,"median":-34.371057,"eighty":-17.876852,"marketCap":3131748819},{"date":"2024-02-16","current":-107.27337,"twenty":-50.169453,"median":-34.371057,"eighty":-17.876852,"marketCap":3198033695},{"date":"2024-02-23","current":-105.929851,"twenty":-50.309576,"median":-34.371057,"eighty":-17.876852,"marketCap":3157980706},{"date":"2024-03-01","current":412.717112,"twenty":-50.298536,"median":-34.214644,"eighty":-17.670729,"marketCap":4511823473},{"date":"2024-03-08","current":438.623542,"twenty":-50.298536,"median":-34.11049,"eighty":-17.456094,"marketCap":4795032559},{"date":"2024-03-15","current":444.731351,"twenty":-50.298536,"median":-34.058413,"eighty":-17.243655,"marketCap":4861803133},{"date":"2024-03-22","current":439.451719,"twenty":-50.298536,"median":-34.058413,"eighty":-17.080779,"marketCap":4804086196},{"date":"2024-03-28","current":458.603326,"twenty":-50.298536,"median":-33.969882,"eighty":-16.958091,"marketCap":5013451555},{"date":"2024-04-05","current":465.539366,"twenty":-50.309576,"median":-33.719912,"eighty":-16.796553,"marketCap":5089276348},{"date":"2024-04-12","current":469.347566,"twenty":-50.309576,"median":-33.084571,"eighty":-16.674704,"marketCap":5130907587},{"date":"2024-04-19","current":427.692121,"twenty":-50.309576,"median":-32.75328,"eighty":-16.501802,"marketCap":4675530271},{"date":"2024-04-26","current":406.068851,"twenty":-50.298536,"median":-32.569008,"eighty":-16.436221,"marketCap":4439144676},{"date":"2024-05-03","current":417.93687,"twenty":-50.298536,"median":-32.4284,"eighty":-16.38783,"marketCap":4568885865},{"date":"2024-05-10","current":79.30624,"twenty":-50.298536,"median":-32.023135,"eighty":-16.247299,"marketCap":4533223973},{"date":"2024-05-17","current":81.826793,"twenty":-50.298536,"median":-31.168135,"eighty":-16.221187,"marketCap":4677301303},{"date":"2024-05-24","current":81.746855,"twenty":-50.298536,"median":-30.861296,"eighty":-16.086794,"marketCap":4672731952},{"date":"2024-05-31","current":80.737634,"twenty":-50.298536,"median":-30.656782,"eighty":-16.021314,"marketCap":4615043904},{"date":"2024-06-07","current":82.77606,"twenty":-50.298536,"median":-30.573158,"eighty":-15.931392,"marketCap":4731562339},{"date":"2024-06-14","current":91.289483,"twenty":-50.309576,"median":-30.424411,"eighty":-15.870101,"marketCap":5218198156},{"date":"2024-06-21","current":85.538925,"twenty":-50.320616,"median":-30.308863,"eighty":-15.845006,"marketCap":4889490512},{"date":"2024-06-28","current":91.364425,"twenty":-50.243436,"median":-30.172403,"eighty":-15.832659,"marketCap":5222481922},{"date":"2024-07-05","current":88.711475,"twenty":-50.030354,"median":-30.064599,"eighty":-15.745878,"marketCap":5070836606},{"date":"2024-07-12","current":99.12593,"twenty":-49.707017,"median":-29.906192,"eighty":-15.692535,"marketCap":5666137288},{"date":"2024-07-15","current":101.486607,"twenty":-49.631513,"median":-29.886841,"eighty":-15.684533,"marketCap":5801075917},{"date":"2024-08-02","current":99.313285,"twenty":-48.900059,"median":-28.925237,"eighty":-15.650295,"marketCap":5676846703},{"date":"2024-08-09","current":48.914679,"twenty":-48.878328,"median":-27.982907,"eighty":-15.581763,"marketCap":5182021081},{"date":"2024-08-16","current":52.605585,"twenty":-48.878328,"median":-27.374676,"eighty":-15.548992,"marketCap":5573035701},{"date":"2024-08-23","current":53.565601,"twenty":-48.878328,"median":-26.655115,"eighty":-15.520349,"marketCap":5674739724},{"date":"2024-08-30","current":52.941862,"twenty":-48.857233,"median":-26.47628,"eighty":-15.490386,"marketCap":5608660839},{"date":"2024-09-06","current":50.457754,"twenty":-48.630719,"median":-26.166781,"eighty":-15.457456,"marketCap":5345494497},{"date":"2024-09-13","current":53.055762,"twenty":-48.460798,"median":-26.068265,"eighty":-15.413334,"marketCap":5620727418},{"date":"2024-09-20","current":50.029273,"twenty":-48.192578,"median":-25.740727,"eighty":-15.39115,"marketCap":5300101176},{"date":"2024-09-27","current":48.383145,"twenty":-48.140297,"median":-25.686376,"eighty":-15.36671,"marketCap":5125710379},{"date":"2024-10-04","current":47.710592,"twenty":-48.140297,"median":-25.447272,"eighty":-15.321442,"marketCap":5054460103},{"date":"2024-10-11","current":46.956682,"twenty":-48.140297,"median":-25.385616,"eighty":-15.281299,"marketCap":4974590842},{"date":"2024-10-18","current":47.951952,"twenty":-48.140297,"median":-25.271568,"eighty":-15.240109,"marketCap":5080029759},{"date":"2024-10-25","current":47.451605,"twenty":-48.140297,"median":-25.171213,"eighty":-15.224652,"marketCap":5027023001},{"date":"2024-10-31","current":47.602116,"twenty":-48.140297,"median":-25.096704,"eighty":-15.205029,"marketCap":5042968123},{"date":"2024-11-08","current":101.841511,"twenty":-48.146106,"median":-24.998383,"eighty":-15.130658,"marketCap":5333643626},{"date":"2024-11-15","current":97.415291,"twenty":-47.879086,"median":-24.91462,"eighty":-15.077305,"marketCap":5101833609},{"date":"2024-11-22","current":100.106169,"twenty":-47.470274,"median":-24.817537,"eighty":-15.048069,"marketCap":5242760294},{"date":"2024-11-29","current":108.414943,"twenty":-46.981573,"median":-24.731231,"eighty":-14.930248,"marketCap":5677907386},{"date":"2024-12-06","current":98.716797,"twenty":-46.556682,"median":-24.688543,"eighty":-14.766359,"marketCap":5169996108},{"date":"2024-12-13","current":95.224147,"twenty":-45.957195,"median":-24.651106,"eighty":-14.731394,"marketCap":4987079023},{"date":"2024-12-20","current":88.32122,"twenty":-45.41369,"median":-24.553429,"eighty":-14.65839,"marketCap":4625558934},{"date":"2024-12-27","current":88.134506,"twenty":-45.180681,"median":-24.428361,"eighty":-14.599772,"marketCap":4615780348},{"date":"2025-01-03","current":85.943362,"twenty":-44.758848,"median":-24.355772,"eighty":-14.550543,"marketCap":4501025762},{"date":"2025-01-10","current":86.036719,"twenty":-44.038175,"median":-24.273244,"eighty":-14.442688,"marketCap":4505915055},{"date":"2025-01-17","current":79.523695,"twenty":-43.941673,"median":-24.162371,"eighty":-14.343029,"marketCap":4164814955},{"date":"2025-01-24","current":85.152573,"twenty":-43.692807,"median":-24.117438,"eighty":-14.205806,"marketCap":4459610572},{"date":"2025-01-31","current":85.707224,"twenty":-43.431749,"median":-24.033689,"eighty":-14.048246,"marketCap":4488658726},{"date":"2025-02-07","current":88.447527,"twenty":-43.23416,"median":-23.960657,"eighty":-13.7871,"marketCap":4632173860},{"date":"2025-02-14","current":85.531493,"twenty":-43.090832,"median":-23.925397,"eighty":-13.666581,"marketCap":4479455351},{"date":"2025-02-21","current":59.002075,"twenty":-42.90401,"median":-23.862754,"eighty":-13.491569,"marketCap":5260565964},{"date":"2025-02-28","current":56.007062,"twenty":-42.713839,"median":-23.782357,"eighty":-13.200775,"marketCap":4993533621},{"date":"2025-03-07","current":57.809885,"twenty":-42.402497,"median":-23.70101,"eighty":-12.237878,"marketCap":5154271536},{"date":"2025-03-14","current":57.30587,"twenty":-42.130534,"median":-23.62904,"eighty":47.292958,"marketCap":5109334054},{"date":"2025-03-21","current":60.937363,"twenty":-42.130534,"median":-23.531246,"eighty":47.579878,"marketCap":5433114371},{"date":"2025-03-28","current":59.044076,"twenty":-42.130534,"median":-23.480942,"eighty":47.967138,"marketCap":5264310754},{"date":"2025-04-04","current":57.551416,"twenty":-42.130534,"median":-23.298076,"eighty":48.348975,"marketCap":5131226674},{"date":"2025-04-11","current":51.903862,"twenty":-42.117793,"median":-23.201379,"eighty":48.571894,"marketCap":4627696430},{"date":"2025-04-17","current":53.212363,"twenty":-42.108146,"median":-23.107672,"eighty":48.798067,"marketCap":4744361046},{"date":"2025-04-25","current":54.81554,"twenty":-41.734951,"median":-23.01592,"eighty":49.395229,"marketCap":4887298760},{"date":"2025-05-02","current":53.703801,"twenty":-41.655942,"median":-22.970987,"eighty":50.025476,"marketCap":4788177221},{"date":"2025-05-09","current":31.978315,"twenty":-41.429199,"median":-22.885854,"eighty":50.376397,"marketCap":3964031935},{"date":"2025-05-16","current":30.383712,"twenty":-41.221012,"median":-22.743811,"eighty":50.376397,"marketCap":3766364964},{"date":"2025-05-23","current":29.208742,"twenty":-41.044653,"median":-22.613428,"eighty":50.376397,"marketCap":3620715617},{"date":"2025-05-30","current":29.283343,"twenty":-40.746006,"median":-22.521507,"eighty":50.376397,"marketCap":3629963194},{"date":"2025-06-06","current":30.917578,"twenty":-40.38983,"median":-22.291149,"eighty":50.376397,"marketCap":3832542941},{"date":"2025-06-13","current":32.715003,"twenty":-40.072518,"median":-22.123914,"eighty":50.376397,"marketCap":4055351764},{"date":"2025-06-20","current":30.794019,"twenty":-39.896405,"median":-21.96429,"eighty":50.427923,"marketCap":3817226641},{"date":"2025-06-27","current":33.239543,"twenty":-39.625462,"median":-21.730175,"eighty":50.427923,"marketCap":4120373794},{"date":"2025-07-03","current":33.356108,"twenty":-39.364195,"median":-21.494087,"eighty":50.427923,"marketCap":4134823134},{"date":"2025-07-11","current":34.908748,"twenty":-39.043119,"median":-20.823509,"eighty":50.427923,"marketCap":4327288343},{"date":"2025-07-17","current":34.988011,"twenty":-38.949071,"median":-20.356335,"eighty":50.427923,"marketCap":4337113894}],"updateTime":1752902794674}}}